Effect of a three-tier prescription copay on pharmaceutical and other medical utilization
B Motheral, KA Fairman - Medical care, 2001 - journals.lww.com
Background. In response to rising prescription drug costs, plan sponsors are increasingly
implementing three-tiered pharmacy benefits. Objective. This study examined the effect of a …
implementing three-tiered pharmacy benefits. Objective. This study examined the effect of a …
[PDF][PDF] A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost
AM Fendrick, DG Smith, ME Chernew… - American Journal of …, 2001 - researchgate.net
Increasing utilization of available drugs, coupled with the sustained development and
marketing of innovative products, is largely responsible for double-digit inflation in this …
marketing of innovative products, is largely responsible for double-digit inflation in this …
Managing prescription drug costs.
JM Sica - Employee Benefits Journal, 2001 - europepmc.org
This article reviews prescription drug cost trends, touching on issues such as cost versus
value, demographic changes, direct-to-consumer advertising, effects of the Internet and …
value, demographic changes, direct-to-consumer advertising, effects of the Internet and …
Pharma rebates, pharmacy benefit managers and employer outcomes
Ö Gür Ali, M Mantrala - Health care management science, 2010 - Springer
Corporate employers contract with pharmacy benefit managers (PBMs) with the goals of
lowering their employee prescription drug coverage costs while maintaining health care …
lowering their employee prescription drug coverage costs while maintaining health care …
Demand for a Medicare prescription drug benefit: exploring consumer preferences under a managed competition framework
RR Cline, DA Mott - INQUIRY: The Journal of Health Care …, 2003 - journals.sagepub.com
Several proposals for adding a prescription drug benefit to the Medicare program rely on
consumer choice and market forces to promote efficiency. However, little information exists …
consumer choice and market forces to promote efficiency. However, little information exists …
Impact of generic and therapeutic interchange incentives on community pharmacy.
NV Carroll - American Pharmacy, 1995 - europepmc.org
The purpose of this project was to estimate the increase in revenues that the average
community pharmacy could expect from generic and therapeutic interchange bonuses …
community pharmacy could expect from generic and therapeutic interchange bonuses …
Choices in prescription-drug benefit programs: mail versus community pharmacy services
DM Kirking, FJ Ascione, JW Richards - The Milbank Quarterly, 1990 - JSTOR
Pharmaceutical price increases and greater coverage of outpatient prescription medications
have stimulated interest in containing drug benefit-program costs. While mail pharmacy …
have stimulated interest in containing drug benefit-program costs. While mail pharmacy …
Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?
SB Soumerai, D Ross‐Degnan, EE Fortess… - The Milbank …, 1997 - Wiley Online Library
Since 1980, many Medicaid programs have instituted, adjusted, or abolished
pharmaceutical copayments or limitations on the number of prescriptions per patient (caps) …
pharmaceutical copayments or limitations on the number of prescriptions per patient (caps) …
Economic impact of cost-containment strategies in third party programmes in the US (Part I)
CE Reeder, EW Lingle, RM Schulz, RP Mauch… - …, 1993 - Springer
The rising cost of healthcare has strained the resources of governments, private third parties
and individuals with responsibility to pay for it. Various strategies have been used in an …
and individuals with responsibility to pay for it. Various strategies have been used in an …
[PDF][PDF] Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey
Background: Three-tier pharmaceutical benefit systems use graded co-payments to steer
patients toward “preferred” formulary medications. Objectives: To evaluate physicians' …
patients toward “preferred” formulary medications. Objectives: To evaluate physicians' …